Clinical trial · Interventional
Using e-Technologies to Maximize Physical Activity After Cancer Treatment
Using e-Technologies to Maximize Physical Activity After Cancer Treatment: The eMPACT Trial
NCT07535918CI-TRIAL-00124255not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Cancer Exercise app (CEA) is designed to promote physical activity among cancer survivors. The proposed randomized controlled clinical trial will investigate, in adults who have completed cancer treatment, the effects of a 12-week home-based exercise program, delivered using CEA, on physical activity levels. Participants will be randomized into one of two groups: (1) CEA or (2) Usual Care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cancer Exercise App | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Cancer Exercise app group
- interventionNames
- Behavioral: Cancer Exercise App
- type
- NO_INTERVENTION
- label
- Usual Care group
- description
- Participants assigned to Usual Care group will receive no intervention. After completing the post-intervention assessments, they will be provided with information on how to download and use the Cancer exercise app.
Primary outcomes (1)
- measure
- Change in moderate to vigorous physical activity from pre- to post-intervention
- timeFrame
- Baseline and following the 12-week intervention
- description
- Moderate to vigorous physical activity will be assessed using the International Physical Activity Questionnaire, a well-validated and reproducible questionnaire for use among cancer survivors
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * 18 to 85 years of age * Diagnosed with stage I-III cancer * Completed all primary cancer treatments (e.g., surgery, radiation, chemotherapy) at least 6 months prior to enrollment. Adjuvant endocrine therapy, CDK4/6 inhibitors, PARP inhibitors, immunotherapy, and bisphosphonates are allowed within 6 months of study enrolment and during study participation. * Own a smartphone with data plan or access to WiFi (Apple or Android) * Medical clearance provided or no medical clearance needed based on exercise preparticipation screening. Exclusion Criteria: * consistently engage in \>300 min/week of moderate-intensity physical activity or 150 min/week of vigorous-intensity physical activity in the past 3 months * receiving or scheduled to receive surgery or radiation during study participation * have stage IV metastatic cancer or evidence of cancer recurrence * have multiple myeloma * have received bone marrow or hematopoietic stem cell transplant within past year * are unable to walk without support or have severe weakness or balance problems that limit safe participation in exercise * contraindications to participate in unsupervised exercise * are pregnant * unable to read, speak and understand English
References
Publications (0)
Data not yet available
No reference posted for this study.